🚀 VC round data is live in beta, check it out!
Nestmedic Overview
About Nestmedic
Nestmedic SA is a manufacturer of mobile telemedicine solution Pregnabit for remote fetal well-being - cardiotocographic (KTG). Pregnabit consists of a medical device (teleKTG) allowing to reliably and safely retrieve data using certified medical probes.
Founded
2017
HQ
Employees
19
Website
Sectors
Financials (FY)
EV
$9M
Nestmedic Financials
Nestmedic reported last fiscal year revenue of $284K and negative EBITDA of ($895K).
In the same fiscal year, Nestmedic generated $227K in gross profit, ($895K) in EBITDA losses, and had net loss of ($1M).
Nestmedic P&L
In the most recent fiscal year, Nestmedic reported revenue of $284K and EBITDA of ($895K).
Nestmedic expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $284K | XXX | XXX | XXX |
| Gross Profit | — | XXX | $227K | XXX | XXX | XXX |
| Gross Margin | — | XXX | 80% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($895K) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (316%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (400%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($1M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (430%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Nestmedic Stock Performance
Nestmedic has current market cap of $9M, and enterprise value of $9M.
Market Cap Evolution
Nestmedic's stock price is $0.18.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $9M | $9M | 0.1% | XXX | XXX | XXX | $-0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNestmedic Valuation Multiples
Nestmedic trades at 31.5x EV/Revenue multiple, and (10.0x) EV/EBITDA.
Nestmedic Financial Valuation Multiples
As of April 20, 2026, Nestmedic has market cap of $9M and EV of $9M.
Equity research analysts estimate Nestmedic's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Nestmedic has a P/E ratio of (7.5x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $9M | XXX | $9M | XXX | XXX | XXX |
| EV (current) | $9M | XXX | $9M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 31.5x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (10.0x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (7.9x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 39.4x | XXX | XXX | XXX |
| P/E | — | XXX | (7.5x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (68.4x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Nestmedic Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Nestmedic Margins & Growth Rates
Nestmedic's revenue in the last fiscal year grew by 5%.
Nestmedic's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.1M for the same period.
Nestmedic Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (316%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (22%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 480% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Nestmedic Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Nestmedic | XXX | XXX | XXX | XXX | XXX | XXX |
| Bluelinea | XXX | XXX | XXX | XXX | XXX | XXX |
| Sds Optic | XXX | XXX | XXX | XXX | XXX | XXX |
| AMA Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| Zynex | XXX | XXX | XXX | XXX | XXX | XXX |
| Scandinavian ChemoTech | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nestmedic M&A Activity
Nestmedic acquired XXX companies to date.
Last acquisition by Nestmedic was on XXXXXXXX, XXXXX. Nestmedic acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Nestmedic
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialNestmedic Investment Activity
Nestmedic invested in XXX companies to date.
Nestmedic made its latest investment on XXXXXXXX, XXXXX. Nestmedic invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Nestmedic
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Nestmedic
| When was Nestmedic founded? | Nestmedic was founded in 2017. |
| Where is Nestmedic headquartered? | Nestmedic is headquartered in Poland. |
| How many employees does Nestmedic have? | As of today, Nestmedic has over 19 employees. |
| Is Nestmedic publicly listed? | Yes, Nestmedic is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of Nestmedic? | Nestmedic trades under NST ticker. |
| When did Nestmedic go public? | Nestmedic went public in 2017. |
| Who are competitors of Nestmedic? | Nestmedic main competitors are Bluelinea, Sds Optic, AMA Corp, Zynex. |
| What is the current market cap of Nestmedic? | Nestmedic's current market cap is $9M. |
| What is the current revenue of Nestmedic? | Nestmedic's last fiscal year revenue is $284K. |
| What is the current EV/Revenue multiple of Nestmedic? | Current revenue multiple of Nestmedic is 31.5x. |
| Is Nestmedic profitable? | No, Nestmedic is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.